Upper Extremity and Muscle Oxygenation
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT06294223 |
Recruitment Status :
Recruiting
First Posted : March 5, 2024
Last Update Posted : March 18, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Near-infrared Spectroscopy Muscle Oxygenation | Device: Exercise follow up with near-infrared spectroscopy | Not Applicable |
Our study aims to determine the acute oxygen response in the upper extremity muscles against a resistance exercise fatigue protocol, in order to demonstrate the effect of muscle oxygenation levels on the occurrence of symptoms such as fatigue in upper extremity use, and to provide reference information for the development of exercise programs.
It is known that resistance exercise increases resting energy expenditure and promotes fat oxidation for weight loss. Changes in cardiopulmonary function that occur in chronic diseases reduce oxygen uptake and decrease energy production, leading to increased fatigue. Resistance exercises in chronic diseases can regulate an individual's energy production capacity.
The main objective of our study is to investigate the effect of muscle oxygenation levels on the occurrence of symptoms such as fatigue by determining the oxygen response in the upper extremity muscles based on a resistance exercise protocol.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 30 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Investigation of the Correlation Between Upper Extremity Fatigue Level and Muscle Oxygenation |
Actual Study Start Date : | March 1, 2024 |
Estimated Primary Completion Date : | March 1, 2025 |
Estimated Study Completion Date : | March 1, 2025 |
Arm | Intervention/treatment |
---|---|
Experimental: Measurement of Upper Extremity Muscle Oxygenation
Measuring muscle oxygenation with fatigue protocol.
|
Device: Exercise follow up with near-infrared spectroscopy
Exercises will be followed by near-infrared spectroscopy. Fatigue protocol will be applied. |
- Determination of Blood Pressure [ Time Frame: Measurement will be made before and immediately after exercise. ]Systolic/diastolic blood pressure will be determined with a digital blood pressure monitor and will be recorded in mmHg. Measurements will be taken via the right brachial artery in a comfortable position.
- Saturation Measurement [ Time Frame: Measurement will be made before and immediately after exercise. ]Oxygen saturation will be measured with a pulse oximeter device and recorded on the form.
- Muscle Oxygenation Measurement [ Time Frame: Baseline. ]MOXY Pro (Moxy 3, Firmware 1.1 Hutchinson MN, USA), a near-infrared spectroscopy device, will be used to measure the muscle oxygen rate (SmO2) and total hemoglobin amount (tHb) of the biceps brachii muscle.
- Determination of Heart Rate [ Time Frame: Measurement will be made before and immediately after exercise. ]Heart rate will be determined with a digital blood pressure monitor and will be recorded in BPM.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 30 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Volunteering to participate in the study
- Being over 18 years old
- Having a Body Mass Index (BMI) value between 23-30 kg/m2
- Absence of comorbid disease of the orthopedic, neurological, cardiopulmonery system
Exclusion Criteria:
- Smoking / alcohol use
- Presence of orthopedic disease effecting the upper extremity or previous surgery
- Presence of cardiopulmonery disease that prevents exercise
- Participants who performed resistance exercise regulary for more than 6 months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06294223
Contact: Esra Pehlivan, Ass. Prof | 05058527913 | esra.pehlivan@sbu.edu.tr | |
Contact: Tuna Sümer, PT | 05534422490 | tnasmrgs@gmail.com |
Turkey | |
Saglik Bilimleri University | Recruiting |
Istanbul, Turkey, 34010 | |
Contact: Esra Pehlivan, Ass Prof 05058527913 esra.pehlivan@sbu.edu.tr |
Study Director: | Esra Pehlivan, Ass. Prof. | Saglik Bilimleri Universitesi | |
Principal Investigator: | Mehmet Burak Uyaroğlu, Pt.PhD(c) | Saglik Bilimleri Universitesi | |
Study Chair: | Tuna Sümer, PT | Saglik Bilimleri Universitesi | |
Study Chair: | Melisa Eren, PT | Saglik Bilimleri Universitesi | |
Study Chair: | Ceren Balıkcı, PT | Saglik Bilimleri Universitesi |
Responsible Party: | Tuna Sümer, PT, Saglik Bilimleri Universitesi |
ClinicalTrials.gov Identifier: | NCT06294223 |
Other Study ID Numbers: |
SaglikBilU |
First Posted: | March 5, 2024 Key Record Dates |
Last Update Posted: | March 18, 2024 |
Last Verified: | March 2024 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Near-infrared Spectroscopy Resistance Exercise Exercise Intensity Muscle Oxygenation Muscle Activation |